Oracle Safety Innovation Summit—EMEA

October 7–8, 2024

This event begins in



  • :


  • :


  • :


Join us at our free, in-person event to drive innovation in safety forward

At this year’s summit, you’ll get unparalleled access to the latest pharmacovigilance insights, exclusive networking with Oracle leadership as well as customers and partners, and a deep dive into product roadmaps, innovation strategies, and more. The 2024 summit is an essential event for senior safety leadership, managers of safety, regulatory affairs professionals, and anyone committed to advancing drug safety through innovation in the pharmaceutical and biotech industries.

What to expect at Oracle Safety Innovation Summit EMEA

Latest safety insights : Dive into the latest advancements in pharmacovigilance, with a special focus on the EMEA region's unique challenges and opportunities, presented by industry leaders and Oracle experts.

Networking opportunities : Create valuable connections in pharmacovigilance with Oracle customers and partners, engage with Oracle leadership, and meet key figures in the safety community from across the region.

Leadership engagement : Speak directly with Oracle safety leadership in interactive sessions, gaining an in-depth look into the strategic direction of current and upcoming safety solutions.

Global perspectives, regional focus: Understand how regulatory trends specifically affect the EMEA region as well as on a global level, focusing on how to navigate safety operations within diverse regulatory environments.

Hear from your peers: Learn how your peers are innovating safety within their organizations and gain inspiration and practical guidance on how to transfer key learning experiences to your company.


Times shown in

AI (Generative AI, applications for safety intake)

Signal detection

Product updates (Argus, Empirica, Safety One Intake)

Safety surveillance (real-world evidence, real-world data for safety)

Regulatory compliance

Oracle Analytics

...and many more. Full agenda to be announced soon.

Patient-centric pharmacovigilance: making it a reality (Yvonne Nanciu, Bayer)

Patient centricity continues to be a buzzword, but what is the reality? In this session, Yvonne Nanciu of Bayer will discuss what safety leaders can do to promote a patient-centric approach in pharmacovigilance. She will share practical examples and challenges, as well as future opportunities.

To be announced soon

Featured Speakers

Yvonne Nanciu
Yvonne Nanciu PV Country Head, Deputy EU QPPV, Graduated Plan Officer Germany, Bayer

Yvonne has more than 15 years of pharmacovigilance experience in various global and local positions, including roles at Johnson & Johnson in Germany and AbbVie in Switzerland. She now holds the position of Pharmacovigilance Country Head and QPPV Deputy at Bayer in Germany. Additionally, she is a lecturer for pharmacovigilance, and a passionate advocate for a patient-centric approach in the industry.


Bruce Palsulich
Bruce Palsulich Vice President of Safety, Oracle
Una Kessi
Una Kessi Product Management Director of Safety and Pharmacovigilance, Oracle
Sameer Thapar
Sameer Thapar Strategic Client Advisor, Oracle
Carrie Giannasi
Carrie Giannasi Vice President of Safety Product Management, Oracle
Amit Agrawal
Amit Agrawal Vice President of Software Development, Safety, Oracle
Michael Braun-Boghos
Michael Braun-Boghos Senior Director Safety Strategy, Oracle
Philip Sheridan
Philip Sheridan Principal Solutions Consultant, Oracle
Robert Weber
Robert Weber Product Management Director, Oracle
Patricia Medina
Patricia Medina GM Medical Intelligence, RWE Data & Analytics, Oracle
Baljit Klear
Baljit Klear CRO Alliance Director, Oracle
Lúcia Costa
Lúcia Costa Principal Product Manager, Oracle
Ashwani Bhat
Ashwani Bhat Application Architect, Oracle


Robert Kelle
Robert Kelle Senior Director of Enterprise Safety, Oracle


  • Oracle Utrecht office
    Hertogswetering 163-167
    3543 AS
    Utrecht, Netherlands

Collaborate with industry peers to advance safety

Engage with the Oracle Safety Consortium and participate in meetings, events, roundtable discussions, and working groups to accelerate safety solutions and help shape the future of safety.